Dasatinib Induced Cardiac Tamponade-A Rare Association.

about

Dasatinib Induced Cardiac Tamponade-A Rare Association.

Item

http://www.wikidata.org/entity/Q42293055

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Dasatinib Induced Cardiac Tamponade-A Rare Association.

@en

Dasatinib Induced Cardiac Tamponade-A Rare Association.

@nl

type

Item

label

Dasatinib Induced Cardiac Tamponade-A Rare Association.

@en

Dasatinib Induced Cardiac Tamponade-A Rare Association.

@nl

prefLabel

Dasatinib Induced Cardiac Tamponade-A Rare Association.

@en

Dasatinib Induced Cardiac Tamponade-A Rare Association.

@nl

P1476

Dasatinib Induced Cardiac Tamponade-A Rare Association.

@en

P2093

Gs Naveen Chandra

http://www.w3.org/2001/XMLSchema#string

K Ranjan Shetty

http://www.w3.org/2001/XMLSchema#string

Mugula Sudhakar Rao

http://www.w3.org/2001/XMLSchema#string

Sushant Wattal

http://www.w3.org/2001/XMLSchema#string

U K Abdul Razak

http://www.w3.org/2001/XMLSchema#string

P2860

Extensive pleural and pericardial effusion in chronic myeloid leukemia during treatment with dasatinib at 100 mg or 50 mg daily

New tyrosine kinase inhibitors in chronic myeloid leukemia.

New therapeutic approaches and prognostic factors in chronic myeloid leukemia.

Emerging stem cell concepts for imatinib-resistant chronic myeloid leukaemia: implications for the biology, management, and therapy of the disease.

The occurrence and management of fluid retention associated with TKI therapy in CML, with a focus on dasatinib.

Serosal inflammation (pleural and pericardial effusions) related to tyrosine kinase inhibitors.

Management of drug toxicities in chronic myeloid leukaemia.

Immunosuppression and atypical infections in CML patients treated with dasatinib at 140 mg daily.

Clonal expansion of T/NK-cells during tyrosine kinase inhibitor dasatinib therapy.

P304

FD03-FD04

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.7860/JCDR/2017/24633.9418

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28384883

http://www.w3.org/2001/XMLSchema#string

P932

5376847

http://www.w3.org/2001/XMLSchema#string